Library — CHDR

Search

Filter

Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.

Kleinloog D, Uit den Boogaard A, Dahan A, Mooren R, Klaassen E, Stevens J, Freijer J, van Gerven J

Journal of psychopharmacology (Oxford, England), 2015 Mar; 29(4):401-13

View publication
Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.

Heuberger JA, Guan Z, Oyetayo OO, Klumpers L, Morrison PD, Beumer TL, van Gerven JM, Cohen AF, Freijer J

Clinical pharmacokinetics, 2015 Jan; 54(2):209-19

View publication
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol.

Kleinloog D, Stevens J, Heuberger J, Spinhoven P, van Gerven J

Psychiatry research, 2014 Dec; 220(3):945-53

View publication
Profiling the subjective effects of Δ⁹-tetrahydrocannabinol using visual analogue scales.

Kleinloog D, Roozen F, De Winter W, Freijer J, Van Gerven J

International journal of methods in psychiatric research, 2014 May; 23(2):245-56

View publication
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

Klumpers LE, Fridberg M, de Kam ML, Little PB, Jensen NO, Kleinloog HD, Elling CE, van Gerven JM

British journal of clinical pharmacology, 2013 Nov; 76(6):846-57

View publication
Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.

Klumpers LE, Cole DM, Khalili-Mahani N, Soeter RP, Te Beek ET, Rombouts SA, van Gerven JM

NeuroImage, 2012 Nov; 63(3):1701-11

View publication
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

Liem-Moolenaar M, de Boer P, Timmers M, Schoemaker RC, van Hasselt JG, Schmidt S, van Gerven JM

British journal of clinical pharmacology, 2011 May; 71(6):886-98

View publication
A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.

Jacobs GE, van Gerven JM, de Kam Ml, Elassaiss-Schaap J, Ruigt G, van Pelt J, Peeters BW, Peeters PA, Hulskotte EG

Journal of psychopharmacology (Oxford, England), 2011 Feb; 25(3):361-9

View publication
Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers.

Zoethout RW, Delgado WL, Ippel AE, Dahan A, van Gerven JM

British journal of clinical pharmacology, 2011 Feb; 71(3):331-50

View publication

«
1
2
3
4
5
6
»